DDOG insider sale notice — 15,337 vested shares to be sold via Morgan Stanley
Rhea-AI Filing Summary
Datadog, Inc. (DDOG) Form 144: This notice reports a proposed sale of 15,337 shares of Class A common stock by or for the account of the named person, to be executed through Morgan Stanley Smith Barney LLC on 09/02/2025 on NASDAQ. The filing states these shares were acquired on 09/01/2025 upon vesting of restricted stock units and performance stock units and were received as compensation. The aggregate market value of the shares to be sold is reported as $2,096,261.16, against 323,270,704 shares outstanding. The filer also discloses multiple recent sales by Olivier Pomel between 06/02/2025 and 08/27/2025, listing specific trade dates, share amounts, and gross proceeds.
Positive
- Clear source of shares disclosed: the 15,337 shares were acquired via RSU and PSU vesting and are reported as compensation.
- Broker and execution details provided: Morgan Stanley Smith Barney LLC is named and the planned trade date (09/02/2025) and exchange (NASDAQ) are specified.
- Recent sale history disclosed: multiple prior sales by Olivier Pomel are listed with dates and gross proceeds, improving transparency.
Negative
- Insider selling activity: several sizable sales by the same individual occurred between 06/02/2025 and 08/27/2025, which may be viewed negatively by some market participants.
- Form lacks context on trading plan: the filing does not state whether sales are under a written 10b5-1 plan or the plan adoption date, if any.
Insights
TL;DR: Insider proposes a single-day sale of vested equity; recent frequent disposals indicate ongoing monetization of compensation.
The filing shows a planned sale of 15,337 Class A shares acquired via RSU/PSU vesting on 09/01/2025 and intended for sale on 09/02/2025 through Morgan Stanley Smith Barney LLC. The disposition is explicitly described as arising from compensation. The document also details multiple prior sales by Olivier Pomel from 06/02/2025 through 08/27/2025 with material gross proceeds reported on each date. From an investor disclosure perspective, this is routine Form 144 reporting of proposed restricted-share sales rather than an event indicating company operational changes. The filing contains no information about material nonpublic issues or changes to company performance.
TL;DR: The filing documents compliance with Rule 144 for sale of recently vested compensation shares, with full signature attestations.
The notice identifies the source of the shares as RSU/PSU vesting and records the broker and planned sale date, consistent with standard Rule 144 disclosures. The signature attestation language affirms no undisclosed material adverse information, and the form references adherence to applicable trading-plan or 10b5-1 conditions if adopted. No executive departures, governance changes, or regulatory issues are referenced in this filing; it is limited to transfer/sale reporting obligations.